Skip to main content
Log in

Vascularity of Intrahepatic Cholangiocarcinoma on Computed Tomography is Predictive of Lymph Node Metastasis

  • Hepatobiliary Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The indications for lymph node dissection (LND) for intrahepatic cholangiocarcinoma (ICC) are controversial.

Methods

Seventy patients with mass-forming dominant ICC underwent hepatectomy with systematic LND or lymph node sampling between 2003 and 2013. We defined the computed tomography (CT) ratio as the CT value (Hounsfield units) of the tumor divided by the CT value (Hounsfield units) of the liver parenchyma in the late arterial phase, and investigated the indications for LND with hepatectomy for ICC.

Results

A multivariate analysis identified lymph node metastasis (LNM; n = 19, p = 0.012) and perineural invasion (p = 0.017) as independent predictors of survival. The median survival time and 5-year survival rate in patients exhibiting LNM were 31.1 months and 16.0 %, respectively. In a subgroup analysis of patients without LNM, overall survival was comparable between patients treated with LND and those treated without LND (p = 0.801). A multivariate analysis of the preoperatively measurable parameters revealed that a CT ratio <0.88 and macroscopic periductal infiltration were independently associated with LNM. We developed a score predicting LNM of mass-forming dominant ICC (LMIC score), assigning 1 point for each of these risk factors. The percentages of patients with LNM with an LMIC score of 0, 1, or 2 points were 0, 35, and 58 %, respectively.

Conclusions

The vascularity of ICC is associated with important prognostic factors, LNM, and perineural invasion. LN dissection would be conducted in patients with an LMIC score of one or two points but can be omitted in patients with an LMIC score of zero.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Lang H, Sotiropoulos GC, Fruhauf NR, et al. Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg. 2005;241:134–43

    PubMed  PubMed Central  Google Scholar 

  2. Yamamoto M, Takasaki K, Yoshikawa T. Lymph node metastasis in intrahepatic cholangiocarcinoma. Jpn J Clin Oncol. 1999;29:147–50

    Article  CAS  PubMed  Google Scholar 

  3. Yamamoto Y, Shimada K, Sakamoto Y, et al. Clinicopathological characteristics of intrahepatic cholangiocellular carcinoma presenting intrahepatic bile duct growth. J Surg Oncol. 2009;99:161–5

    Article  PubMed  Google Scholar 

  4. Shimada K, Sano T, Sakamoto Y, et al. Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World J Surg. 2007;31:2016–22

    Article  PubMed  Google Scholar 

  5. Inoue K, Makuuchi M, Takayama T, et al. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery. 2000;127:498–505

    Article  CAS  PubMed  Google Scholar 

  6. Tsuji T, Hiraoka T, Kanemitsu K, et al. Lymphatic spreading pattern of intrahepatic cholangiocarcinoma. Surgery. 2001;129:401–7

    Article  CAS  PubMed  Google Scholar 

  7. Shimada M, Yamashita Y, Aishima S, et al. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg. 2001;88:1463–6

    Article  CAS  PubMed  Google Scholar 

  8. Ohtsuka M, Ito H, Kimura F, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg. 2002;89:1525–31

    Article  CAS  PubMed  Google Scholar 

  9. Shirabe K, Shimada M, Harimoto N, et al. Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery. 2002;131:159–64

    Article  Google Scholar 

  10. Shimada K, Sano T, Nara S, et al. Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery. 2009;145:411–6

    Article  PubMed  Google Scholar 

  11. Uenishi T, Yamazaki O, Horii K, et al. A long-term survivor of intrahepatic cholangiocarcinoma with paraaortic lymph node metastasis. J Gastroenterol. 2006;41:391–2

    Article  PubMed  Google Scholar 

  12. Akatsu T, Shimazu M, Kawachi S, et al. Long-term survival of intrahepatic cholangiocarcinoma with hilar lymph node metastasis and portal vein involvement. Hepatogastroenterology. 2005;52:603–5

    PubMed  Google Scholar 

  13. Asakura H, Ohtsuka M, Ito H, et al. Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis. Hepatogastroenterology. 2005;52:722–4

    PubMed  Google Scholar 

  14. Kobayashi S, Tomokuni A, Gotoh K, et al. Evaluation of the safety and pathological effects of neoadjuvant full-dose gemcitabine combination radiation therapy in patients with biliary tract cancer. Cancer Chemother Pharmacol. 2015;76:1191–8

    Article  CAS  PubMed  Google Scholar 

  15. Park MS, Lee DK, Kim MJ, et al. Preoperative staging accuracy of multidetector row computed tomography for extrahepatic bile duct carcinoma. J Comput Assist Tomogr. 2006;30:362–7

    Article  PubMed  Google Scholar 

  16. Xu J, Sasaki M, Harada K, et al. Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis. Histopathology. 2011;59:1090–9

    Article  PubMed  Google Scholar 

  17. Nakanuma Y, Sasaki M, Ikeda H, et al. Pathology of peripheral intrahepatic cholangiocarcinoma with reference to tumorigenesis. Hepatol Res. 2008;38:325–34

    Article  PubMed  Google Scholar 

  18. Xu J, Igarashi S, Sasaki M, et al. Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers. Liver Int. 2012;32:1156–64

    Article  PubMed  Google Scholar 

  19. Yoshida Y, Imai Y, Murakami T, et al. Intrahepatic cholangiocarcinoma with marked hypervascularity. Abdom Imaging. 1999;24:66–8

    Article  CAS  PubMed  Google Scholar 

  20. Ariizumi S, Kotera Y, Takahashi Y, et al. Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes. J Surg Oncol. 2011;104:130–9

    Article  PubMed  Google Scholar 

  21. Yamamoto M, Ariizumi S, Otsubo T, et al. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma. J Surg Oncol. 2004;87:80–3

    Article  PubMed  Google Scholar 

  22. Asayama Y, Yoshimitsu K, Irie H, et al. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology. 2006;238:150–5

    Article  PubMed  Google Scholar 

  23. Nanashima A, Sumida Y, Abo T, et al. Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma. J Surg Oncol. 2008;98:535–9

    Article  PubMed  Google Scholar 

  24. Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer. 3rd English ed. Tokyo: Kanehara; 2010

  25. Uno M, Shimada K, Yamamoto Y, et al. Periductal infiltrating type of intrahepatic cholangiocarcinoma: a rare macroscopic type without any apparent mass. Surg Today. 2012;42:1189–94

    Article  PubMed  Google Scholar 

  26. Ebata T, Kosuge T, Hirano S et al. Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas. Br J Surg. 2014;101:79–88

    Article  CAS  PubMed  Google Scholar 

  27. Compton CC, Byrd DR, Garcia-Aguilar J, et al.. American Joint Committee on Cancer. Cancer staging atlas: a companion to the seventh editions of the AJCC cancer staging manual and handbook. 2nd ed. Springer, New York; 2009

  28. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrics. 1994;81:515–9

    Article  Google Scholar 

  29. Roche CJ, Hughes ML, Garvey CJ, et al. CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. AJR Am J Roentgenol. 2003;180:475–80

    Article  PubMed  Google Scholar 

  30. Horgan AM, Amir E, Walter T et al. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol. 2012;30:1934–40.

    Article  PubMed  Google Scholar 

  31. Nathan H, Aloia TA, Vauthey JN et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2009;16:14–22

    Article  PubMed  Google Scholar 

Download references

DISCLOSURE

Yusuke Yamamoto, Mehmet Akif Türkoğlu, Takeshi Aramaki, Teiichi Sugiura, Yukiyasu Okamura, Takaaki Ito, Ryo Ashida, Sunao Uemura, Takashi Miyata, Yoshiyasu Kato, Yuko Kakuta, Yasuni Nakanuma, and Katsuhiko Uesaka declare no conflicts of interest in association with this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yusuke Yamamoto MD.

Additional information

This paper is not based on a previous communication to a society or meeting.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamamoto, Y., Türkoğlu, M.A., Aramaki, T. et al. Vascularity of Intrahepatic Cholangiocarcinoma on Computed Tomography is Predictive of Lymph Node Metastasis. Ann Surg Oncol 23 (Suppl 4), 485–493 (2016). https://doi.org/10.1245/s10434-016-5382-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-016-5382-1

Keywords

Navigation